17-31232043-ATTTTTTTTTTTTTTT-ATTTTT

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP6_ModerateBS2_Supporting

The NM_001042492.3(NF1):​c.3198-13_3198-4delTTTTTTTTTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 0)
Exomes 𝑓: 0.000034 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

NF1
NM_001042492.3 splice_region, intron

Scores

Not classified

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: 3.14

Publications

2 publications found
Variant links:
Genes affected
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]
NF1 Gene-Disease associations (from GenCC):
  • neurofibromatosis type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Genomics England PanelApp
  • neurofibromatosis-Noonan syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia
  • Moyamoya disease
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP6
Variant 17-31232043-ATTTTTTTTTT-A is Benign according to our data. Variant chr17-31232043-ATTTTTTTTTT-A is described in ClinVar as Likely_benign. ClinVar VariationId is 3048484.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 10 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NF1NM_001042492.3 linkc.3198-13_3198-4delTTTTTTTTTT splice_region_variant, intron_variant Intron 24 of 57 ENST00000358273.9 NP_001035957.1
NF1NM_000267.4 linkc.3198-13_3198-4delTTTTTTTTTT splice_region_variant, intron_variant Intron 24 of 56 NP_000258.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NF1ENST00000358273.9 linkc.3198-29_3198-20delTTTTTTTTTT intron_variant Intron 24 of 57 1 NM_001042492.3 ENSP00000351015.4

Frequencies

GnomAD3 genomes
AF:
0.000110
AC:
10
AN:
90908
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.000178
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000135
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000424
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000835
Gnomad OTH
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000341
AC:
17
AN:
499010
Hom.:
0
AF XY:
0.0000343
AC XY:
9
AN XY:
262428
show subpopulations
African (AFR)
AF:
0.000295
AC:
3
AN:
10162
American (AMR)
AF:
0.00
AC:
0
AN:
16036
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
12226
East Asian (EAS)
AF:
0.000119
AC:
2
AN:
16804
South Asian (SAS)
AF:
0.0000233
AC:
1
AN:
42948
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
28846
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1682
European-Non Finnish (NFE)
AF:
0.0000287
AC:
10
AN:
348458
Other (OTH)
AF:
0.0000458
AC:
1
AN:
21848
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000110
AC:
10
AN:
90904
Hom.:
0
Cov.:
0
AF XY:
0.0000951
AC XY:
4
AN XY:
42042
show subpopulations
African (AFR)
AF:
0.000178
AC:
4
AN:
22460
American (AMR)
AF:
0.000135
AC:
1
AN:
7430
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2612
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2712
South Asian (SAS)
AF:
0.000425
AC:
1
AN:
2352
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
3380
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
174
European-Non Finnish (NFE)
AF:
0.0000835
AC:
4
AN:
47880
Other (OTH)
AF:
0.00
AC:
0
AN:
1226
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.530
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
224
Bravo
AF:
0.0000642

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

NF1-related disorder Benign:1
Jul 14, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype Benign:1
Feb 27, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.1
Mutation Taster
=99/1
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371047262; hg19: chr17-29559061; API